Eric Cantor was named the next president and chief executive officer of PhRMA, effective Nov. 9.
James B. Yu was named associate director for clinical research at Dartmouth Cancer Center.
Eric Cantor named president and CEO of PhRMA
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
What should a cancer center look like in an era of AI, genomics, complex patient populations, rising costs, and declining public trust in science?
Heidi Overton, President Trump’s nominee for FDA Commissioner, defended the agency’s recent policy decisions reversing its hardball stance on flavored nicotine products, as she appeared in front of the Senate Committee on Health, Education, Labor, and Pensions on Sept 24.
Rutika Mehta has joined NYU Langone Health’s Perlmutter Cancer Center as director of upper GI medical oncology.
The Colorectal Cancer Alliance has announced the appointment of four members to its board of directors.
Following a national search, NCI has selected Senthil K. Muthuswamy as the next director of the Center for Cancer Research. He assumed the role July 26.
